BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8401404)

  • 1. Analysis of skin penetration enhancement based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities.
    Yamashita F; Yoshioka T; Koyama Y; Okamoto H; Sezaki H; Hashida M
    Biol Pharm Bull; 1993 Jul; 16(7):690-7. PubMed ID: 8401404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.
    Yamashita F; Bando H; Koyama Y; Kitagawa S; Takakura Y; Hashida M
    Pharm Res; 1994 Feb; 11(2):185-91. PubMed ID: 8165175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-alkyl- or 1-alkenylazacycloalkanone derivatives on the penetration of drugs with different lipophilicities through guinea pig skin.
    Okamoto H; Hashida M; Sezaki H
    J Pharm Sci; 1991 Jan; 80(1):39-45. PubMed ID: 2013848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of percutaneous absorption enhancement by d-limonene and oleic acid based on a skin diffusion model.
    Koyama Y; Bando H; Yamashita F; Takakura Y; Sezaki H; Hashida M
    Pharm Res; 1994 Mar; 11(3):377-83. PubMed ID: 8008702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of drug penetration through the skin by the two-layer skin model.
    Okamoto H; Yamashita F; Saito K; Hashida M
    Pharm Res; 1989 Nov; 6(11):931-7. PubMed ID: 2594684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical design of prodrug-enhancer combination based on a skin diffusion model: prediction of permeation of acyclovir prodrugs treated with 1-geranylazacycloheptan-2-one.
    Bando H; Takagi T; Yamashita F; Takakura Y; Hashida M
    Pharm Res; 1996 Mar; 13(3):427-32. PubMed ID: 8692736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil.
    Cornwell PA; Barry BW
    J Pharm Pharmacol; 1994 Apr; 46(4):261-9. PubMed ID: 8051608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers.
    Okamoto H; Hashida M; Sezaki H
    J Pharm Sci; 1988 May; 77(5):418-24. PubMed ID: 3411465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin penetration enhancement of acyclovir by prodrug-enhancer combination.
    Bando H; Yamashita F; Takakura Y; Hashida M
    Biol Pharm Bull; 1994 Aug; 17(8):1141-3. PubMed ID: 7820127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine.
    Southwell D; Barry BW
    J Invest Dermatol; 1983 Jun; 80(6):507-14. PubMed ID: 6854051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of drug penetration through skin considering donor concentration decrease.
    Hashida M; Okamoto H; Sezaki H
    J Pharmacobiodyn; 1988 Sep; 11(9):636-44. PubMed ID: 3216285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug.
    Moser K; Kriwet K; Froehlich C; Kalia YN; Guy RH
    Pharm Res; 2001 Jul; 18(7):1006-11. PubMed ID: 11496937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives.
    Sato S; Hirotani Y; Ogura N; Sasaki E; Kitagawa S
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):831-6. PubMed ID: 9621418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.
    Sugibayashi K; Hosoya K; Morimoto Y; Higuchi WI
    J Pharm Pharmacol; 1985 Aug; 37(8):578-80. PubMed ID: 2864423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum.
    Singh BN; Singh RB; Singh J
    Int J Pharm; 2005 Jul; 298(1):98-107. PubMed ID: 15913928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent enhancement effects of azone on skin permeability.
    Lambert WJ; Higuchi WI; Knutson K; Krill SL
    Pharm Res; 1989 Sep; 6(9):798-803. PubMed ID: 2813277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of skin penetration-enhancing effect by laurocapram.
    Sugibayashi K; Nakayama S; Seki T; Hosoya K; Morimoto Y
    J Pharm Sci; 1992 Jan; 81(1):58-64. PubMed ID: 1619571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique.
    Goodman M; Barry BW
    J Invest Dermatol; 1988 Oct; 91(4):323-7. PubMed ID: 3171212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
    He N; Warner KS; Higuchi WI; Li SK
    Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum.
    Harrison JE; Watkinson AC; Green DM; Hadgraft J; Brain K
    Pharm Res; 1996 Apr; 13(4):542-6. PubMed ID: 8710743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.